IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 51.366
EU - Europa 31.094
AS - Asia 26.045
SA - Sud America 5.379
AF - Africa 656
OC - Oceania 140
Continente sconosciuto - Info sul continente non disponibili 110
Totale 114.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.473
SG - Singapore 9.629
GB - Regno Unito 7.250
RU - Federazione Russa 7.236
CN - Cina 6.541
IT - Italia 5.454
BR - Brasile 4.200
VN - Vietnam 3.642
UA - Ucraina 2.331
DE - Germania 2.306
CA - Canada 2.204
HK - Hong Kong 1.963
DK - Danimarca 1.529
BD - Bangladesh 1.371
FR - Francia 1.115
FI - Finlandia 840
SE - Svezia 819
IN - India 564
IE - Irlanda 549
PL - Polonia 535
MX - Messico 474
AR - Argentina 434
NL - Olanda 378
TR - Turchia 327
IL - Israele 279
ID - Indonesia 248
EC - Ecuador 215
IQ - Iraq 214
ZA - Sudafrica 211
PK - Pakistan 209
JP - Giappone 202
ES - Italia 184
CO - Colombia 137
AT - Austria 114
VE - Venezuela 112
EU - Europa 106
AU - Australia 104
UZ - Uzbekistan 100
MA - Marocco 99
SA - Arabia Saudita 90
CL - Cile 86
KR - Corea 76
AE - Emirati Arabi Uniti 67
PY - Paraguay 67
IR - Iran 66
KE - Kenya 64
LT - Lituania 62
EG - Egitto 61
PH - Filippine 61
MY - Malesia 57
PE - Perù 55
TN - Tunisia 52
RO - Romania 48
JO - Giordania 46
CH - Svizzera 41
DZ - Algeria 41
BE - Belgio 39
CR - Costa Rica 35
NP - Nepal 35
JM - Giamaica 34
BO - Bolivia 33
NZ - Nuova Zelanda 33
UY - Uruguay 33
AZ - Azerbaigian 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
SK - Slovacchia (Repubblica Slovacca) 30
TH - Thailandia 30
HN - Honduras 28
PT - Portogallo 27
KZ - Kazakistan 23
TW - Taiwan 22
GR - Grecia 21
DO - Repubblica Dominicana 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
TT - Trinidad e Tobago 17
AL - Albania 16
OM - Oman 16
HU - Ungheria 15
NI - Nicaragua 15
PA - Panama 15
QA - Qatar 15
GE - Georgia 13
GT - Guatemala 13
AM - Armenia 12
LV - Lettonia 12
RS - Serbia 12
BY - Bielorussia 11
NO - Norvegia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
MK - Macedonia 10
BA - Bosnia-Erzegovina 9
HR - Croazia 9
MD - Moldavia 9
Totale 114.597
Salva come PNG Salva come JPEG
Città #
Dallas 8.053
Southend 4.837
Singapore 4.814
San Jose 2.981
Ashburn 2.954
Beijing 2.740
Woodbridge 2.675
Chandler 2.320
Ann Arbor 2.295
Houston 2.106
Hong Kong 1.745
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Jacksonville 1.106
Seattle 1.092
Los Angeles 1.026
Dearborn 1.020
Ho Chi Minh City 994
Cambridge 967
Wilmington 888
Ottawa 865
The Dalles 794
New York 733
Chicago 649
Pisa 645
Hanoi 624
Hefei 542
Boardman 538
Dublin 522
Lauterbourg 513
Stevenage 512
Portsmouth 502
Warsaw 491
Dong Ket 483
Santa Clara 473
São Paulo 440
Helsinki 426
Buffalo 422
Montréal 403
Lawrence 385
Rome 341
Milan 329
Brooklyn 320
Beauharnois 315
Council Bluffs 276
London 257
Tel Aviv 251
Munich 247
Orem 244
Salt Lake City 229
Mexico City 212
Montreal 200
Florence 192
Frankfurt am Main 181
San Diego 176
Redwood City 175
Tokyo 165
Old Bridge 158
Denver 154
Stockholm 152
Chennai 150
Istanbul 148
Rio de Janeiro 144
Toronto 142
Atlanta 141
Poplar 141
Amsterdam 134
Da Nang 134
Johannesburg 134
Phoenix 126
Haiphong 119
Tampa 113
Elk Grove Village 111
Fremont 111
Boston 109
Nuremberg 108
Manchester 92
Naples 90
Tashkent 90
San Francisco 88
Ankara 78
Bologna 78
Biên Hòa 74
Belo Horizonte 72
Brasília 71
Curitiba 71
Mumbai 71
Washington 71
Turku 69
Baghdad 68
Norwalk 68
Guayaquil 67
Paris 66
Shanghai 66
Quito 65
Dhaka 64
Livorno 64
Lucca 64
Totale 69.484
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.697
Value in Healthcare and the Role of the Patient Voice 1.191
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 691
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 611
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 592
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 494
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 492
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 469
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 459
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 438
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 419
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 396
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 391
A simple echocardiographic score to rule out cardiac amyloidosis 377
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 373
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 366
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 359
Human pathophysiological adaptations to the space environment 357
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 349
A simple echocardiographic score to rule out cardiac amyloidosis 346
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 346
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 345
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 338
La neuropatia diabetica 337
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 333
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 333
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 331
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 329
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 329
[Central apneas and cardiovascular diseases] 326
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 326
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 325
Treating chemoreflex in heart failure: modulation or demolition? 324
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 322
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 322
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 321
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 319
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 319
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 319
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 319
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 318
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 316
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 313
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 311
The evolution of TAVI performance overtime: an overview of systematic reviews 309
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 309
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 308
Adrenergic activation in heart failure: blockade or rebalance? 308
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 306
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 305
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 305
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 304
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 302
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 301
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 299
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 299
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 298
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 297
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 297
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 297
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 296
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 295
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 295
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 295
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 292
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 291
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 290
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 288
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 288
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 288
Screening the health status of people working in a university 287
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 286
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 285
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 285
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 285
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 284
Eligibility for vericiguat in a real‐world, contemporary heart failure population 283
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 283
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 283
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 283
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 283
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 281
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 281
Sex-related differences in chronic heart failure 280
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 278
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 277
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 277
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 276
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 275
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 275
How to take arms against central apneas in heart failure 275
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 272
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 271
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 271
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 270
Totale 35.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 567.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 567.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.353 0 0 0 0 0 0 0 0 0 0 0 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202648.641 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 3.260 3.163 653
Totale 115.451